LinkedInXFacebook
Subscribe
Orthopedics This Week
  • Posts
  • |My Feed
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Pain Management & Rehabilitation/Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions
Pain Management & Rehabilitation

Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions

July 23, 2026 3 min read Premium comments

Advertisement

Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions
Courtesy of Curonix and AAOS
chronic painAAOSpain managementCuronix LLCFreedomPNS

POMPANO BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, is supporting the American Academy of Orthopaedic Surgeons’ (AAOS) Pain Management Resource Center at a time when tens of millions of Americans are living with acute and chronic pain1 and clinicians face growing demand for safer, more personalized approaches to treatment.

Studies show that many patients still struggle to access effective, individualized care, underscoring the growing need for trusted resources that support better decision-making for both clinicians and patients.

To help address these challenges, orthopaedic surgeons must balance effective pain relief with evolving prescribing guidance, patient expectations and ongoing concerns about opioid safety. The AAOS Pain Management Resource Center was developed to provide centralized access to practical tools, clinical guidance and educational resources tailored specifically to musculoskeletal care.

The publicly available online hub is designed to help orthopaedic surgeons and patients make more informed decisions about pain care before, during and after treatment while promoting patient-centered care.

"At Curonix, we are committed to advancing patient-centered solutions that help people living with chronic pain better understand their options and work with their care teams to find the right path forward," said Aure Bruneau, CEO of Curonix. "By supporting trusted educational resources like the AAOS Pain Management Resource Center, we are helping clinicians and patients access evidence-based information that can support more effective, informed pain management decisions."

The new online pain management resource supports decision-making across the full continuum of orthopaedic care – not just postoperative recovery – by offering targeted resources for both clinicians and patients.

For patients and caregivers, the Pain Management Resource Center offers:

  • Visual guides to help explain pain, recovery and treatment options at a glance

  • Tools to support conversations with care teams about medications, recovery plans and next steps

  • Practical information on nutrition, recovery strategies and opioid safety

  • For orthopaedic surgeons and care teams, resources include:

    • Perioperative pain management strategies tailored to orthopaedic procedures

  • Topic-based pathways that guide clinicians to relevant learning and practical content for common pain management challenges

  • Advertisement

  • Access to CME opportunities through the AAOS learning environment

  • "We are grateful for the support of Curonix in helping make the Pain Management Resource Center possible," said Mike Weinand, AAOS director, product development and delivery. "Through collaboration with our founding and supporting partners, AAOS is able to expand access to trusted educational resources that support informed pain management decisions and patient-centered care."

    The AAOS Pain Management Resource Center is available at http://aaos.org/pain

    For more information about Curonix, visit us at http://curonix.com.

    References:
    1. https://www.vrtx.com/stories/state-pain-america/

    About Curonix LLC
    Curonix LLC is a Delaware-based medical technology company dedicated to developing and commercializing innovative therapies designed to help relieve chronic pain. Its proprietary Freedom® PNS System is a minimally invasive, permanent peripheral nerve stimulation system powered by High-Frequency Electromagnetic Coupling (HF-EMC) and does not include an implanted battery. The system includes a two-component implantable neurostimulator, an externally worn transmitter, and software used to create patient-specific stimulation programs. The Freedom PNS System is the first and only permanent PNS system in the United States that is MR Conditional for scans throughout the body and over the implanted device at both 1.5T and 3T.*

    *See the Instructions for Use at http://curonix.com for complete MR conditions.

    About AAOS
    With more than 39,000 members, the American Academy of Orthopaedic Surgeons is the world’s largest medical association of musculoskeletal specialists. AAOS is the trusted leader in advancing musculoskeletal health. It provides the highest quality, most comprehensive education to help orthopaedic surgeons and allied health professionals at every career level best treat patients daily. AAOS is the source of information on bone and joint conditions, treatments, and related musculoskeletal healthcare issues; and it leads the healthcare discussion on advancing quality.

    Follow AAOS on Facebook, X, LinkedIn, and Instagram.

    Contact Information:
    Ashley Brown
    Sr. Director of Marketing & Communications, Curonix
    Ashley.Brown@curonix.com
    512-791-4743

    Why This Matters

    Two Perspectives

    MBA Lens: Economic and industry impact

    Curonix LLC is strategically supporting the AAOS Pain Management Resource Center, aiming to address the significant market need for safer, patient-centered chronic pain solutions amidst opioid safety concerns. This collaboration positions Curonix to influence clinical decision-making and patient education, potentially fostering broader adoption of innovative pain management approaches. The initiative provides orthopaedic surgeons and patients with trusted, evidence-based resources to navigate treatment options.

    • Curonix's support for AAOS's resource center aligns with a strategy to promote informed decision-making in a growing pain management market.
    • The partnership helps address the demand for personalized, safer care, potentially creating a favorable environment for Curonix's proprietary technologies.

    PhD Lens: Clinical and outcomes impact

    Curonix LLC, a medical technology company, is supporting the AAOS Pain Management Resource Center, which aims to provide clinicians and patients with evidence-based information and clinical guidance for musculoskeletal pain. Curonix's proprietary Freedom® PNS System is a minimally invasive, permanent peripheral nerve stimulation device utilizing High-Frequency Electromagnetic Coupling (HF-EMC) without an implanted battery. It is notably MR Conditional for scans at 1.5T and 3T.

    • The Freedom® PNS System employs High-Frequency Electromagnetic Coupling for peripheral nerve stimulation, distinguishing it by not requiring an implanted battery.
    • A key safety and usability feature is its MR Conditional status for full-body and over-device scans at both 1.5T and 3T.
    React:

    Discussion

    14
    DS
    Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

    This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

    8
    JT
    James Thornton, MDSpine Fellow · HSS

    Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

    5
    RP
    R. PatelSports Medicine · Stanford

    We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

    Join the conversation

    Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

    Subscribe

    Get Full Access

    Read every OTW article and join member discussions for $24.99/month.

    Get Full Access

    Advertisement

    Advertisement

    Advertisement

    Orthopedics This Week

    The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

    A publication of RRY Publications, LLC

    LinkedInXFacebook

    Categories

    • Spine
    • Joints
    • Upper Extremities
    • Foot & Ankle
    • Sports Medicine
    • Pain Mgmt
    • Trauma
    • Biologics
    • Technology
    • People
    • Company News
    • Legal & Regulatory

    Resources

    • Subscribe
    • Community Posts
    • Job Board
    • Press Release Opportunities
    • Power Rankings
    • About OTW
    • Advertise
    • Contact Us

    Get Full Access

    Unlimited articles, community posts, and Power Rankings.

    Get Full Access

    Plans start at $24.99/mo · Annual saves 20%

    © 2026 Orthopedics This Week · RRY Publications, LLC

    Privacy PolicyTerms of ServiceCookie Policy